Summit X, LLC Bluebird Bio, Inc. Transaction History
Summit X, LLC
- $423 Million
- Q3 2024
A detailed history of Summit X, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Summit X, LLC holds 567,831 shares of BLUE stock, worth $3.99 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
567,831
Previous 582,461
2.51%
Holding current value
$3.99 Million
Previous $570,000
48.25%
% of portfolio
0.07%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding BLUE
# of Institutions
128Shares Held
62.8MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$73.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$32.9 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$32.8 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$27 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $542M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...